心不全と心伝導障害が先行した抗ミトコンドリアM2抗体陽性筋炎の69歳男性例

症例は69歳男性.2年前より心不全症状が出現し,洞不全症候群に対しペースメーカー植込み術を受けた.1年前より歩行時に両下肢の疲労感が出現した.近位筋の筋力低下,腰椎前弯の増強,筋CTで胸腰椎傍脊柱筋,腹直筋,ヒラメ筋の萎縮を認めた.血清CK値は1,455 U/lであった.筋病理では軽度から中等度の筋線維の大小不同,壊死再生線維を認めたが,細胞浸潤は無く,HLA-ABCの発現は僅かであった.抗ミトコンドリアM2抗体が陽性であり,プレドニゾロンの投与により臨床所見の改善を得た.抗ミトコンドリアM2抗体陽性筋炎は筋生検で診断が確定し難く,致死的な心合併症が先行・合併しうることに注意が必要である....

Full description

Saved in:
Bibliographic Details
Published in臨床神経学 Vol. 62; no. 2; pp. 135 - 139
Main Authors 濱口, 眞衣, 藤田, 裕明, 西野, 一三, 鈴木, 圭輔, 大垣, 圭太郎, 国分, 則人
Format Journal Article
LanguageJapanese
Published 日本神経学会 2022
Subjects
Online AccessGet full text
ISSN0009-918X
1882-0654
DOI10.5692/clinicalneurol.cn-001644

Cover

Abstract 症例は69歳男性.2年前より心不全症状が出現し,洞不全症候群に対しペースメーカー植込み術を受けた.1年前より歩行時に両下肢の疲労感が出現した.近位筋の筋力低下,腰椎前弯の増強,筋CTで胸腰椎傍脊柱筋,腹直筋,ヒラメ筋の萎縮を認めた.血清CK値は1,455 U/lであった.筋病理では軽度から中等度の筋線維の大小不同,壊死再生線維を認めたが,細胞浸潤は無く,HLA-ABCの発現は僅かであった.抗ミトコンドリアM2抗体が陽性であり,プレドニゾロンの投与により臨床所見の改善を得た.抗ミトコンドリアM2抗体陽性筋炎は筋生検で診断が確定し難く,致死的な心合併症が先行・合併しうることに注意が必要である.
AbstractList 症例は69歳男性.2年前より心不全症状が出現し,洞不全症候群に対しペースメーカー植込み術を受けた.1年前より歩行時に両下肢の疲労感が出現した.近位筋の筋力低下,腰椎前弯の増強,筋CTで胸腰椎傍脊柱筋,腹直筋,ヒラメ筋の萎縮を認めた.血清CK値は1,455 U/lであった.筋病理では軽度から中等度の筋線維の大小不同,壊死再生線維を認めたが,細胞浸潤は無く,HLA-ABCの発現は僅かであった.抗ミトコンドリアM2抗体が陽性であり,プレドニゾロンの投与により臨床所見の改善を得た.抗ミトコンドリアM2抗体陽性筋炎は筋生検で診断が確定し難く,致死的な心合併症が先行・合併しうることに注意が必要である.
Author 鈴木, 圭輔
藤田, 裕明
国分, 則人
大垣, 圭太郎
西野, 一三
濱口, 眞衣
Author_xml – sequence: 1
  fullname: 濱口, 眞衣
  organization: 獨協医科大学脳神経内科
– sequence: 1
  fullname: 藤田, 裕明
  organization: 獨協医科大学脳神経内科
– sequence: 1
  fullname: 西野, 一三
  organization: 国立精神・神経医療研究センターメディカルゲノム・センターゲノム診療開発部
– sequence: 1
  fullname: 鈴木, 圭輔
  organization: 獨協医科大学脳神経内科
– sequence: 1
  fullname: 大垣, 圭太郎
  organization: 獨協医科大学脳神経内科
– sequence: 1
  fullname: 国分, 則人
  organization: 獨協医科大学脳神経内科
BookMark eNpVUM1KAlEYvYRBZr5DLzB2Z-6dn7sM6Q-sNgXthju3OzYyjTHaol3jIFiamwIpCqlNEiiBi1pkPcx1NN-iEYMIPs53znc-zuIsgoRX9DgAyzLMqBpRVpjreA6jrsdP_aKbYZ4EoaxhPAeSsmEoEtRUnABJCCGRiGwcLIB0qeRYU60SQ8ZJkI--wuH7VVTtiKAz5R8P0Wtzcncf9foiaETV2vdjQwQtEbRHly0RtkVYE5W-COO5EOGLqDxtK7EzHFxPbgej8-dxtz6uNEXQ08io2x_fvMW34Wd9Cczb1C3x9O9Ogf31tb3sppTb3djKruakAkKwLBEOMYc6tIliEG4bqoqgzglH6qHOLE4MzTKQrCuxthnBOkZY5cyyMOWybVGCUmBnllsolWmemye-c0z9M5P6ZYe53PzfmKkppjIF5pmz5v4ej6hvFij6ASrPkeY
ContentType Journal Article
Copyright 2022 日本神経学会
Copyright_xml – notice: 2022 日本神経学会
DOI 10.5692/clinicalneurol.cn-001644
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1882-0654
EndPage 139
ExternalDocumentID article_clinicalneurol_62_2_62_cn_001644_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
OK1
P2P
RJT
ID FETCH-LOGICAL-j330t-9e04e070f9289ef855307e9e35d7cbe986b8317235dfc9474345ecbb4ae1fba93
ISSN 0009-918X
IngestDate Wed Sep 03 06:30:48 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j330t-9e04e070f9289ef855307e9e35d7cbe986b8317235dfc9474345ecbb4ae1fba93
OpenAccessLink https://www.jstage.jst.go.jp/article/clinicalneurol/62/2/62_cn-001644/_article/-char/ja
PageCount 5
ParticipantIDs jstage_primary_article_clinicalneurol_62_2_62_cn_001644_article_char_ja
PublicationCentury 2000
PublicationDate 2022-00-00
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – year: 2022
  text: 2022-00-00
PublicationDecade 2020
PublicationTitle 臨床神経学
PublicationTitleAlternate 臨床神経学
PublicationYear 2022
Publisher 日本神経学会
Publisher_xml – name: 日本神経学会
References 1) Miyakawa H, Kitazawa E, Fujikawa H, et al. Analysis of two major anti-M2 antibodies (anti-PDC-E2/anti-BCOADC-E2) in primary biliary cirrhosis: relationship to titers of immuno­fluorescent anti-mitochondrial antibody. Hepatol Res 2000;18:1-9.
13) Uenaka T, Kowa H, Sekiguchi K, et al. Myositis with antimitochondrial antibodies diagnosed by rectus abdominis muscle biopsy. Muscle Nerve 2013;47:766-768.
11) Shimazaki R, Uruha A, Kimura H, et al. Rimmed vacuoles in myositis associated with antimitochondrial antibody. J Clin Neurol 2020;16:510-512.
2) Maeda MH, Tsuji S, Shimizu J. Inflammatory myopathies associated with anti-mitochondrial antibodies. Brain 2012;135:1767-1777.
12) Shimizu H, Nishino I, Ueda T, et al. Anti-mitochondrial antibody-associated myositis with eosinophilia and dropped head. eNeurologicalSci 2018;11:15-16.
9) Brogna C, Cristiano L, Verdolotti T, et al. MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients. J Neurol 2020;267:898-912.
6) Albayda J, Khan A, Casciola-Rosen L, et al. Inflammatory myopathy associated with anti-mitochondrial antibodies: a distinct phenotype with cardiac involvement. Semin Arthritis Rheum 2018;47:552-556.
3) Uenaka T, Kowa H, Ohtsuka Y, et al. Less limb muscle involvement in myositis patients with anti-mitochondrial antibodies. Eur Neurol 2017;78:290-295.
7) Hou Y, Liu M, Luo YB, et al. Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: clinical features and treatment outcomes in a Chinese cohort. Neuromuscul Disord 2019;29:5-13.
5) Mauhin W, Mariampillai K, Allenbach Y, et al. Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies. Joint Bone Spine 2018;85:375-376.
4) Uhl GS, Baldwin JL, Arnett FC. Primary biliary cirrhosis in systrmic sclerosis (scleroderma) and polymyositis. Johns Hopkins Med J 1974;135:191-198.
8) Minamiyama S, Ueda S, Nakashima R, et al. Thigh muscle MRI findings in myopathy associated with anti-mitochondrial antibody. Muscle Nerve 2020;61:81-87.
10) Johnson MA, Polgar J, Weightman D, et al. Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci 1973;18:111-129.
References_xml – reference: 11) Shimazaki R, Uruha A, Kimura H, et al. Rimmed vacuoles in myositis associated with antimitochondrial antibody. J Clin Neurol 2020;16:510-512.
– reference: 4) Uhl GS, Baldwin JL, Arnett FC. Primary biliary cirrhosis in systrmic sclerosis (scleroderma) and polymyositis. Johns Hopkins Med J 1974;135:191-198.
– reference: 7) Hou Y, Liu M, Luo YB, et al. Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: clinical features and treatment outcomes in a Chinese cohort. Neuromuscul Disord 2019;29:5-13.
– reference: 13) Uenaka T, Kowa H, Sekiguchi K, et al. Myositis with antimitochondrial antibodies diagnosed by rectus abdominis muscle biopsy. Muscle Nerve 2013;47:766-768.
– reference: 2) Maeda MH, Tsuji S, Shimizu J. Inflammatory myopathies associated with anti-mitochondrial antibodies. Brain 2012;135:1767-1777.
– reference: 9) Brogna C, Cristiano L, Verdolotti T, et al. MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients. J Neurol 2020;267:898-912.
– reference: 6) Albayda J, Khan A, Casciola-Rosen L, et al. Inflammatory myopathy associated with anti-mitochondrial antibodies: a distinct phenotype with cardiac involvement. Semin Arthritis Rheum 2018;47:552-556.
– reference: 12) Shimizu H, Nishino I, Ueda T, et al. Anti-mitochondrial antibody-associated myositis with eosinophilia and dropped head. eNeurologicalSci 2018;11:15-16.
– reference: 5) Mauhin W, Mariampillai K, Allenbach Y, et al. Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies. Joint Bone Spine 2018;85:375-376.
– reference: 8) Minamiyama S, Ueda S, Nakashima R, et al. Thigh muscle MRI findings in myopathy associated with anti-mitochondrial antibody. Muscle Nerve 2020;61:81-87.
– reference: 10) Johnson MA, Polgar J, Weightman D, et al. Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. J Neurol Sci 1973;18:111-129.
– reference: 1) Miyakawa H, Kitazawa E, Fujikawa H, et al. Analysis of two major anti-M2 antibodies (anti-PDC-E2/anti-BCOADC-E2) in primary biliary cirrhosis: relationship to titers of immuno­fluorescent anti-mitochondrial antibody. Hepatol Res 2000;18:1-9.
– reference: 3) Uenaka T, Kowa H, Ohtsuka Y, et al. Less limb muscle involvement in myositis patients with anti-mitochondrial antibodies. Eur Neurol 2017;78:290-295.
SSID ssib000959814
ssib058494234
ssib002821941
ssib000940416
ssib002484599
ssib005879791
ssj0060813
Score 2.320612
Snippet ...
SourceID jstage
SourceType Publisher
StartPage 135
SubjectTerms ヒラメ筋
体幹筋罹患
心不全
心伝導障害
抗ミトコンドリアM2抗体陽性筋炎
Title 心不全と心伝導障害が先行した抗ミトコンドリアM2抗体陽性筋炎の69歳男性例
URI https://www.jstage.jst.go.jp/article/clinicalneurol/62/2/62_cn-001644/_article/-char/ja
Volume 62
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 臨床神経学, 2022, Vol.62(2), pp.135-139
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1daxNB8CgVxBfxE78qfXAfU5O9vbudx73kYlEiCC307chdLkqQKCV98ck0FKqtfVEoilL0xSK0CH3QB6s_5prW_gtn9u6Si6hoEcIxtzszuzOzx8xs9sMwrpU4eZXQKjS4FRSEbEAhEGFYsLkTNuwQwrq-vq12256eFTfnrLmx8YncqqWFTjAVPvrlvpKjWBXL0K60S_YfLDtgigUIo33xiRbG51_ZmHkWc6tMmswTzJVMVqhEWkxJ5pkYJGogj1NmoHHcIpMe84CBYlCmEuUx10ypZDnlI5FcMpWU6CpwMqDKPJtJlZWYukQDMmmdZwzNISAhBZRKcRSv8Rwn7GOFgam7BgRTVZEprHKYqjDpEoB01P1ERM8GwsJKasZhgDycHB2-ekiXD8NJKulk2lHUOLG3GHgEuFaqAuSpBlOXxBI16Za0cqpMmTQ-dYtlTag1pcwhviSRlMg6VUzwJVGCRewAu-Hl8ZU2FgqPvZNegp-YtpgBMMQHUrUrNKcySaPxLf1SIXZkb5Gf2OHDCQBNpYVOyct_0EE2eNSIlwN0YvrKZvTxiWOjTIo2Euc9n81zXzjPubFScoRMGhGVkuOmfna2lg10eG-2g1efv3p_KmwX9LFtYhhgDJZ9ph-KP0ri29zn9AjbfkLqDxDv1ef9FqY_x7jjlGjF7q07uewBRHHkT3OwQOYWBXAhhQUjswul_LZtSzrgDI-KwlAcMLkQWSBnY7Q8uIiR1JksBCSxr_9OaIxjW5jVZStCdZA6c8o4mWaXkyoR7LQx1qqfMY7X0vUzZ427_W-9vc_P-kubcXeT4C9v-h_XDl-97m_vxN3V_tLy97ercXc97m7sP12Pextxbzle3Il7-HsS9z7Ei-9qHGv2dp8fvtzdf_z-YGvlYHEt7m7bsL-1c_DiE5btfV05Z8xWvZnydCG9aqXQMs1ipwBRUUTo_ZvAJURNSZeJORFEptVwwiACaQcSMw2O780QBKYdworCIBD1qNQM6mCeN8bbD9rRBWNS8JA3IWyiBwBRd9AAAV2HZjsNoPV35kXjRqIi_2Fyno5_1GFx6b9xumycoC8wmVq9Yox35heiCUw2OsFVPeR-AP44_xE
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%BF%83%E4%B8%8D%E5%85%A8%E3%81%A8%E5%BF%83%E4%BC%9D%E5%B0%8E%E9%9A%9C%E5%AE%B3%E3%81%8C%E5%85%88%E8%A1%8C%E3%81%97%E3%81%9F%E6%8A%97%E3%83%9F%E3%83%88%E3%82%B3%E3%83%B3%E3%83%89%E3%83%AA%E3%82%A2M2%E6%8A%97%E4%BD%93%E9%99%BD%E6%80%A7%E7%AD%8B%E7%82%8E%E3%81%AE69%E6%AD%B3%E7%94%B7%E6%80%A7%E4%BE%8B&rft.jtitle=%E8%87%A8%E5%BA%8A%E7%A5%9E%E7%B5%8C%E5%AD%A6&rft.au=%E6%BF%B1%E5%8F%A3%2C+%E7%9C%9E%E8%A1%A3&rft.au=%E8%97%A4%E7%94%B0%2C+%E8%A3%95%E6%98%8E&rft.au=%E8%A5%BF%E9%87%8E%2C+%E4%B8%80%E4%B8%89&rft.au=%E9%88%B4%E6%9C%A8%2C+%E5%9C%AD%E8%BC%94&rft.date=2022&rft.pub=%E6%97%A5%E6%9C%AC%E7%A5%9E%E7%B5%8C%E5%AD%A6%E4%BC%9A&rft.issn=0009-918X&rft.eissn=1882-0654&rft.volume=62&rft.issue=2&rft.spage=135&rft.epage=139&rft_id=info:doi/10.5692%2Fclinicalneurol.cn-001644&rft.externalDocID=article_clinicalneurol_62_2_62_cn_001644_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-918X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-918X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-918X&client=summon